HCPLive Network

High In-Utero Pollen Exposure Linked to Asthma in First Year

 
TUESDAY, Jan. 15 (HealthDay News) -- High pollen exposure in utero late in pregnancy is associated with an increased risk of asthma hospitalization during the first year of life, according to a study published online Nov. 7 in Allergy, Asthma & Clinical Immunology.

Adrian J. Lowe, Ph.D., M.P.H., from Umeå University in Sweden, and colleagues assessed the effect of pollen exposure in the first and last 12 weeks of pregnancy and the first 12 weeks of infancy for all children conceived by women residing in Stockholm between 1988 and 1995. Hospital admission data were used to assess respiratory conditions in the first year of life.

The researchers found that, by age 12 months, 940 of 110,381 children had been hospitalized for asthma. There were marked seasonal variations and between-year differences in pollen levels. There was an increased risk of asthma hospitalization for those exposed to high levels of pollen in the last 12 weeks of pregnancy (adjusted odds ratio [aOR], 1.35 for highest quartile versus remaining infants). Among children of mothers who smoked heavily, exposure to high levels of pollen in the first three months of life was associated with a significantly reduced risk of asthma hospitalization (aOR, 0.76).

"Replication of these findings is needed, as the results are somewhat surprising," the authors write. "If replicated, these findings may lead to mechanistic studies that help elucidate the pathogenesis of late pregnancy pollen exposure on respiratory outcomes, which could have therapeutic implications."
 

Abstract
Full Text

Copyright © 2013 HealthDay. All rights reserved.
 
 

Further Reading
Study results show that patients diagnosed with fibromyalgia often discontinue treatment. Those that do not frequently augment their initial treatment regimen with one or more additional medications, including some that are not recommended by current guidelines.
The patient-reported painDETECT questionnaire has been shown to accurately and reliably identify neuropathic pain across a range of conditions.
Knowledge of dietary supplement properties, uses, and contraindications is highly relevant to any health care practitioner that treats patients with chronic pain. Data shows that the top four reasons for supplement use are back pain, neck pain, joint pain, and arthritis.
Research indicates that there are probable etiologies of low back pain that can affect treatment outcome and that ignoring pain can possibly cause chronic neurological changes.
Researchers are learning more about the ways in which gut microbiota interact with the central nervous system and the role this can play in pain management.
Although the underlying mechanisms are not fully understood, opioid-induced hyperalgesia occurs in some patients on higher doses of opioids. Treatment options include reducing, rotating, or completely tapering the opioid regimen.
Magnetic resonance is an effective alternative to biopsy for identifying and quantifying fats in the liver, according to results from a study led by a research team at the University of the Basque Country.
More Reading